 | • レポートコード：GIR-23F3788 • 出版社/出版日：GlobalInfoResearch / 2023年2月 • レポート形態：英文、PDF、118ページ • 納品方法：Eメール（2~3営業日） • 産業分類：医薬品 |
| Single User | ￥501,120 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥751,680 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,002,240 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 「Global Drugs for Asthma and COPD Market」レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 グローバルインフォリサーチ社（香港）の最新の調査によると、世界の喘息及びCOPD治療薬の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。 喘息及びCOPD治療薬市場はタイプ（種類）とアプリケーション（用途）によって区分されます。2017年～2028年において、量と金額の観点からタイプ別およびアプリケーション別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 タイプ別セグメントは次を対象にします。 ・ジェネリック医薬品、特許医薬品 アプリケーション別セグメントは次のように区分されます。 ・喘息、COPD 世界の喘息及びCOPD治療薬市場の主要なマーケットプレーヤーは以下のとおりです。 ・GSK、Novartis、Merck、Abbott、Boehringer Ingelheim、AstraZeneca、Roche、Teva、Vectura、Pfizer、Mylan、Allergan、Cipla、Akorn、Apotex 地域別セグメントは次の地域・国を対象にします。 ・北米市場（米国、カナダ、メキシコ） ・ヨーロッパ市場（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋市場（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南米市場（ブラジル、アルゼンチン、コロンビア） ・中東・アフリカ市場（サウジアラビア、UAE、エジプト、南アフリカ） ***** 目次(一部) ***** ・市場概要 - 喘息及びCOPD治療薬の概要 - タイプ別分析（2017年vs2021年vs2028年）：ジェネリック医薬品、特許医薬品 - アプリケーション別分析（2017年vs2021年vs2028年）：喘息、COPD - 世界の喘息及びCOPD治療薬市場規模・予測 - 世界の喘息及びCOPD治療薬生産能力分析 - 市場の成長要因・阻害要因・動向 ・メーカー情報（企業概要、製品概要、販売量、価格、売上） - GSK、Novartis、Merck、Abbott、Boehringer Ingelheim、AstraZeneca、Roche、Teva、Vectura、Pfizer、Mylan、Allergan、Cipla、Akorn、Apotex ・メーカー別市場シェア・市場集中度 ・地域別市場分析2017年-2028年 ・タイプ別分析2017年-2028年：ジェネリック医薬品、特許医薬品 ・アプリケーション別分析2017年-2028年：喘息、COPD ・喘息及びCOPD治療薬の北米市場分析 - 喘息及びCOPD治療薬の北米市場：タイプ別市場規模2017年-2028年 - 喘息及びCOPD治療薬の北米市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：アメリカ、カナダ、メキシコなど ・喘息及びCOPD治療薬のヨーロッパ市場分析 - ：喘息及びCOPD治療薬のヨーロッパ市場：タイプ別市場規模2017年-2028年 - ：喘息及びCOPD治療薬のヨーロッパ市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど ・喘息及びCOPD治療薬のアジア太平洋市場分析 - 喘息及びCOPD治療薬のアジア太平洋市場：タイプ別市場規模2017年-2028年 - 喘息及びCOPD治療薬のアジア太平洋市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど ・喘息及びCOPD治療薬の南米市場分析 - 喘息及びCOPD治療薬の南米市場：タイプ別市場規模2017年-2028年 - 喘息及びCOPD治療薬の南米市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：ブラジル、アルゼンチンなど ・喘息及びCOPD治療薬の中東・アフリカ市場分析 - 喘息及びCOPD治療薬の中東・アフリカ市場：タイプ別市場規模2017年-2028年 - 喘息及びCOPD治療薬の中東・アフリカ市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Drugs for Asthma and COPD market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Drugs for Asthma and COPD market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Asthma accounting for % of the Drugs for Asthma and COPD global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Generic Drugs segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Drugs for Asthma and COPD include GSK, Novartis, Merck, Abbott, and Boehringer Ingelheim, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Drugs for Asthma and COPD market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Generic Drugs
Patented Drugs
Market segment by Application can be divided into
Asthma
COPD
The key market players for global Drugs for Asthma and COPD market are listed below:
GSK
Novartis
Merck
Abbott
Boehringer Ingelheim
AstraZeneca
Roche
Teva
Vectura
Pfizer
Mylan
Allergan
Cipla
Akorn
Apotex
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Drugs for Asthma and COPD product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Drugs for Asthma and COPD, with price, sales, revenue and global market share of Drugs for Asthma and COPD from 2019 to 2022.
Chapter 3, the Drugs for Asthma and COPD competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Drugs for Asthma and COPD breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Drugs for Asthma and COPD market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Drugs for Asthma and COPD.
Chapter 13, 14, and 15, to describe Drugs for Asthma and COPD sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Drugs for Asthma and COPD Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Drugs for Asthma and COPD Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Generic Drugs
1.2.3 Patented Drugs
1.3 Market Analysis by Application
1.3.1 Overview: Global Drugs for Asthma and COPD Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Asthma
1.3.3 COPD
1.4 Global Drugs for Asthma and COPD Market Size & Forecast
1.4.1 Global Drugs for Asthma and COPD Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Drugs for Asthma and COPD Sales in Volume (2017-2028)
1.4.3 Global Drugs for Asthma and COPD Price (2017-2028)
1.5 Global Drugs for Asthma and COPD Production Capacity Analysis
1.5.1 Global Drugs for Asthma and COPD Total Production Capacity (2017-2028)
1.5.2 Global Drugs for Asthma and COPD Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Drugs for Asthma and COPD Market Drivers
1.6.2 Drugs for Asthma and COPD Market Restraints
1.6.3 Drugs for Asthma and COPD Trends Analysis
2 Manufacturers Profiles
2.1 GSK
2.1.1 GSK Details
2.1.2 GSK Major Business
2.1.3 GSK Drugs for Asthma and COPD Product and Services
2.1.4 GSK Drugs for Asthma and COPD Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Novartis
2.2.1 Novartis Details
2.2.2 Novartis Major Business
2.2.3 Novartis Drugs for Asthma and COPD Product and Services
2.2.4 Novartis Drugs for Asthma and COPD Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Merck
2.3.1 Merck Details
2.3.2 Merck Major Business
2.3.3 Merck Drugs for Asthma and COPD Product and Services
2.3.4 Merck Drugs for Asthma and COPD Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Abbott
2.4.1 Abbott Details
2.4.2 Abbott Major Business
2.4.3 Abbott Drugs for Asthma and COPD Product and Services
2.4.4 Abbott Drugs for Asthma and COPD Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Boehringer Ingelheim
2.5.1 Boehringer Ingelheim Details
2.5.2 Boehringer Ingelheim Major Business
2.5.3 Boehringer Ingelheim Drugs for Asthma and COPD Product and Services
2.5.4 Boehringer Ingelheim Drugs for Asthma and COPD Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 AstraZeneca
2.6.1 AstraZeneca Details
2.6.2 AstraZeneca Major Business
2.6.3 AstraZeneca Drugs for Asthma and COPD Product and Services
2.6.4 AstraZeneca Drugs for Asthma and COPD Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Roche
2.7.1 Roche Details
2.7.2 Roche Major Business
2.7.3 Roche Drugs for Asthma and COPD Product and Services
2.7.4 Roche Drugs for Asthma and COPD Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Teva
2.8.1 Teva Details
2.8.2 Teva Major Business
2.8.3 Teva Drugs for Asthma and COPD Product and Services
2.8.4 Teva Drugs for Asthma and COPD Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Vectura
2.9.1 Vectura Details
2.9.2 Vectura Major Business
2.9.3 Vectura Drugs for Asthma and COPD Product and Services
2.9.4 Vectura Drugs for Asthma and COPD Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Pfizer
2.10.1 Pfizer Details
2.10.2 Pfizer Major Business
2.10.3 Pfizer Drugs for Asthma and COPD Product and Services
2.10.4 Pfizer Drugs for Asthma and COPD Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Mylan
2.11.1 Mylan Details
2.11.2 Mylan Major Business
2.11.3 Mylan Drugs for Asthma and COPD Product and Services
2.11.4 Mylan Drugs for Asthma and COPD Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Allergan
2.12.1 Allergan Details
2.12.2 Allergan Major Business
2.12.3 Allergan Drugs for Asthma and COPD Product and Services
2.12.4 Allergan Drugs for Asthma and COPD Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 Cipla
2.13.1 Cipla Details
2.13.2 Cipla Major Business
2.13.3 Cipla Drugs for Asthma and COPD Product and Services
2.13.4 Cipla Drugs for Asthma and COPD Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14 Akorn
2.14.1 Akorn Details
2.14.2 Akorn Major Business
2.14.3 Akorn Drugs for Asthma and COPD Product and Services
2.14.4 Akorn Drugs for Asthma and COPD Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15 Apotex
2.15.1 Apotex Details
2.15.2 Apotex Major Business
2.15.3 Apotex Drugs for Asthma and COPD Product and Services
2.15.4 Apotex Drugs for Asthma and COPD Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Drugs for Asthma and COPD Breakdown Data by Manufacturer
3.1 Global Drugs for Asthma and COPD Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Drugs for Asthma and COPD Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Drugs for Asthma and COPD
3.4 Market Concentration Rate
3.4.1 Top 3 Drugs for Asthma and COPD Manufacturer Market Share in 2021
3.4.2 Top 6 Drugs for Asthma and COPD Manufacturer Market Share in 2021
3.5 Global Drugs for Asthma and COPD Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Drugs for Asthma and COPD Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Drugs for Asthma and COPD Market Size by Region
4.1.1 Global Drugs for Asthma and COPD Sales in Volume by Region (2017-2028)
4.1.2 Global Drugs for Asthma and COPD Revenue by Region (2017-2028)
4.2 North America Drugs for Asthma and COPD Revenue (2017-2028)
4.3 Europe Drugs for Asthma and COPD Revenue (2017-2028)
4.4 Asia-Pacific Drugs for Asthma and COPD Revenue (2017-2028)
4.5 South America Drugs for Asthma and COPD Revenue (2017-2028)
4.6 Middle East and Africa Drugs for Asthma and COPD Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Drugs for Asthma and COPD Sales in Volume by Type (2017-2028)
5.2 Global Drugs for Asthma and COPD Revenue by Type (2017-2028)
5.3 Global Drugs for Asthma and COPD Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Drugs for Asthma and COPD Sales in Volume by Application (2017-2028)
6.2 Global Drugs for Asthma and COPD Revenue by Application (2017-2028)
6.3 Global Drugs for Asthma and COPD Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Drugs for Asthma and COPD Sales by Type (2017-2028)
7.2 North America Drugs for Asthma and COPD Sales by Application (2017-2028)
7.3 North America Drugs for Asthma and COPD Market Size by Country
7.3.1 North America Drugs for Asthma and COPD Sales in Volume by Country (2017-2028)
7.3.2 North America Drugs for Asthma and COPD Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Drugs for Asthma and COPD Sales by Type (2017-2028)
8.2 Europe Drugs for Asthma and COPD Sales by Application (2017-2028)
8.3 Europe Drugs for Asthma and COPD Market Size by Country
8.3.1 Europe Drugs for Asthma and COPD Sales in Volume by Country (2017-2028)
8.3.2 Europe Drugs for Asthma and COPD Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Drugs for Asthma and COPD Sales by Type (2017-2028)
9.2 Asia-Pacific Drugs for Asthma and COPD Sales by Application (2017-2028)
9.3 Asia-Pacific Drugs for Asthma and COPD Market Size by Region
9.3.1 Asia-Pacific Drugs for Asthma and COPD Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Drugs for Asthma and COPD Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Drugs for Asthma and COPD Sales by Type (2017-2028)
10.2 South America Drugs for Asthma and COPD Sales by Application (2017-2028)
10.3 South America Drugs for Asthma and COPD Market Size by Country
10.3.1 South America Drugs for Asthma and COPD Sales in Volume by Country (2017-2028)
10.3.2 South America Drugs for Asthma and COPD Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Drugs for Asthma and COPD Sales by Type (2017-2028)
11.2 Middle East & Africa Drugs for Asthma and COPD Sales by Application (2017-2028)
11.3 Middle East & Africa Drugs for Asthma and COPD Market Size by Country
11.3.1 Middle East & Africa Drugs for Asthma and COPD Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Drugs for Asthma and COPD Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Drugs for Asthma and COPD and Key Manufacturers
12.2 Manufacturing Costs Percentage of Drugs for Asthma and COPD
12.3 Drugs for Asthma and COPD Production Process
12.4 Drugs for Asthma and COPD Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Drugs for Asthma and COPD Typical Distributors
13.3 Drugs for Asthma and COPD Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
Table 1. Global Drugs for Asthma and COPD Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Drugs for Asthma and COPD Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. GSK Basic Information, Manufacturing Base and Competitors
Table 4. GSK Major Business
Table 5. GSK Drugs for Asthma and COPD Product and Services
Table 6. GSK Drugs for Asthma and COPD Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Novartis Basic Information, Manufacturing Base and Competitors
Table 8. Novartis Major Business
Table 9. Novartis Drugs for Asthma and COPD Product and Services
Table 10. Novartis Drugs for Asthma and COPD Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Merck Basic Information, Manufacturing Base and Competitors
Table 12. Merck Major Business
Table 13. Merck Drugs for Asthma and COPD Product and Services
Table 14. Merck Drugs for Asthma and COPD Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Abbott Basic Information, Manufacturing Base and Competitors
Table 16. Abbott Major Business
Table 17. Abbott Drugs for Asthma and COPD Product and Services
Table 18. Abbott Drugs for Asthma and COPD Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 20. Boehringer Ingelheim Major Business
Table 21. Boehringer Ingelheim Drugs for Asthma and COPD Product and Services
Table 22. Boehringer Ingelheim Drugs for Asthma and COPD Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 24. AstraZeneca Major Business
Table 25. AstraZeneca Drugs for Asthma and COPD Product and Services
Table 26. AstraZeneca Drugs for Asthma and COPD Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Roche Basic Information, Manufacturing Base and Competitors
Table 28. Roche Major Business
Table 29. Roche Drugs for Asthma and COPD Product and Services
Table 30. Roche Drugs for Asthma and COPD Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Teva Basic Information, Manufacturing Base and Competitors
Table 32. Teva Major Business
Table 33. Teva Drugs for Asthma and COPD Product and Services
Table 34. Teva Drugs for Asthma and COPD Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Vectura Basic Information, Manufacturing Base and Competitors
Table 36. Vectura Major Business
Table 37. Vectura Drugs for Asthma and COPD Product and Services
Table 38. Vectura Drugs for Asthma and COPD Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Pfizer Basic Information, Manufacturing Base and Competitors
Table 40. Pfizer Major Business
Table 41. Pfizer Drugs for Asthma and COPD Product and Services
Table 42. Pfizer Drugs for Asthma and COPD Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Mylan Basic Information, Manufacturing Base and Competitors
Table 44. Mylan Major Business
Table 45. Mylan Drugs for Asthma and COPD Product and Services
Table 46. Mylan Drugs for Asthma and COPD Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. Allergan Basic Information, Manufacturing Base and Competitors
Table 48. Allergan Major Business
Table 49. Allergan Drugs for Asthma and COPD Product and Services
Table 50. Allergan Drugs for Asthma and COPD Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 51. Cipla Basic Information, Manufacturing Base and Competitors
Table 52. Cipla Major Business
Table 53. Cipla Drugs for Asthma and COPD Product and Services
Table 54. Cipla Drugs for Asthma and COPD Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 55. Akorn Basic Information, Manufacturing Base and Competitors
Table 56. Akorn Major Business
Table 57. Akorn Drugs for Asthma and COPD Product and Services
Table 58. Akorn Drugs for Asthma and COPD Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 59. Apotex Basic Information, Manufacturing Base and Competitors
Table 60. Apotex Major Business
Table 61. Apotex Drugs for Asthma and COPD Product and Services
Table 62. Apotex Drugs for Asthma and COPD Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 63. Global Drugs for Asthma and COPD Sales by Manufacturer (2019, 2020, 2021, and 2022) & (MT)
Table 64. Global Drugs for Asthma and COPD Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 65. Market Position of Manufacturers in Drugs for Asthma and COPD, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 66. Global Drugs for Asthma and COPD Production Capacity by Company, (MT): 2020 VS 2021
Table 67. Head Office and Drugs for Asthma and COPD Production Site of Key Manufacturer
Table 68. Drugs for Asthma and COPD New Entrant and Capacity Expansion Plans
Table 69. Drugs for Asthma and COPD Mergers & Acquisitions in the Past Five Years
Table 70. Global Drugs for Asthma and COPD Sales by Region (2017-2022) & (MT)
Table 71. Global Drugs for Asthma and COPD Sales by Region (2023-2028) & (MT)
Table 72. Global Drugs for Asthma and COPD Revenue by Region (2017-2022) & (USD Million)
Table 73. Global Drugs for Asthma and COPD Revenue by Region (2023-2028) & (USD Million)
Table 74. Global Drugs for Asthma and COPD Sales by Type (2017-2022) & (MT)
Table 75. Global Drugs for Asthma and COPD Sales by Type (2023-2028) & (MT)
Table 76. Global Drugs for Asthma and COPD Revenue by Type (2017-2022) & (USD Million)
Table 77. Global Drugs for Asthma and COPD Revenue by Type (2023-2028) & (USD Million)
Table 78. Global Drugs for Asthma and COPD Price by Type (2017-2022) & (USD/Kg)
Table 79. Global Drugs for Asthma and COPD Price by Type (2023-2028) & (USD/Kg)
Table 80. Global Drugs for Asthma and COPD Sales by Application (2017-2022) & (MT)
Table 81. Global Drugs for Asthma and COPD Sales by Application (2023-2028) & (MT)
Table 82. Global Drugs for Asthma and COPD Revenue by Application (2017-2022) & (USD Million)
Table 83. Global Drugs for Asthma and COPD Revenue by Application (2023-2028) & (USD Million)
Table 84. Global Drugs for Asthma and COPD Price by Application (2017-2022) & (USD/Kg)
Table 85. Global Drugs for Asthma and COPD Price by Application (2023-2028) & (USD/Kg)
Table 86. North America Drugs for Asthma and COPD Sales by Country (2017-2022) & (MT)
Table 87. North America Drugs for Asthma and COPD Sales by Country (2023-2028) & (MT)
Table 88. North America Drugs for Asthma and COPD Revenue by Country (2017-2022) & (USD Million)
Table 89. North America Drugs for Asthma and COPD Revenue by Country (2023-2028) & (USD Million)
Table 90. North America Drugs for Asthma and COPD Sales by Type (2017-2022) & (MT)
Table 91. North America Drugs for Asthma and COPD Sales by Type (2023-2028) & (MT)
Table 92. North America Drugs for Asthma and COPD Sales by Application (2017-2022) & (MT)
Table 93. North America Drugs for Asthma and COPD Sales by Application (2023-2028) & (MT)
Table 94. Europe Drugs for Asthma and COPD Sales by Country (2017-2022) & (MT)
Table 95. Europe Drugs for Asthma and COPD Sales by Country (2023-2028) & (MT)
Table 96. Europe Drugs for Asthma and COPD Revenue by Country (2017-2022) & (USD Million)
Table 97. Europe Drugs for Asthma and COPD Revenue by Country (2023-2028) & (USD Million)
Table 98. Europe Drugs for Asthma and COPD Sales by Type (2017-2022) & (MT)
Table 99. Europe Drugs for Asthma and COPD Sales by Type (2023-2028) & (MT)
Table 100. Europe Drugs for Asthma and COPD Sales by Application (2017-2022) & (MT)
Table 101. Europe Drugs for Asthma and COPD Sales by Application (2023-2028) & (MT)
Table 102. Asia-Pacific Drugs for Asthma and COPD Sales by Region (2017-2022) & (MT)
Table 103. Asia-Pacific Drugs for Asthma and COPD Sales by Region (2023-2028) & (MT)
Table 104. Asia-Pacific Drugs for Asthma and COPD Revenue by Region (2017-2022) & (USD Million)
Table 105. Asia-Pacific Drugs for Asthma and COPD Revenue by Region (2023-2028) & (USD Million)
Table 106. Asia-Pacific Drugs for Asthma and COPD Sales by Type (2017-2022) & (MT)
Table 107. Asia-Pacific Drugs for Asthma and COPD Sales by Type (2023-2028) & (MT)
Table 108. Asia-Pacific Drugs for Asthma and COPD Sales by Application (2017-2022) & (MT)
Table 109. Asia-Pacific Drugs for Asthma and COPD Sales by Application (2023-2028) & (MT)
Table 110. South America Drugs for Asthma and COPD Sales by Country (2017-2022) & (MT)
Table 111. South America Drugs for Asthma and COPD Sales by Country (2023-2028) & (MT)
Table 112. South America Drugs for Asthma and COPD Revenue by Country (2017-2022) & (USD Million)
Table 113. South America Drugs for Asthma and COPD Revenue by Country (2023-2028) & (USD Million)
Table 114. South America Drugs for Asthma and COPD Sales by Type (2017-2022) & (MT)
Table 115. South America Drugs for Asthma and COPD Sales by Type (2023-2028) & (MT)
Table 116. South America Drugs for Asthma and COPD Sales by Application (2017-2022) & (MT)
Table 117. South America Drugs for Asthma and COPD Sales by Application (2023-2028) & (MT)
Table 118. Middle East & Africa Drugs for Asthma and COPD Sales by Region (2017-2022) & (MT)
Table 119. Middle East & Africa Drugs for Asthma and COPD Sales by Region (2023-2028) & (MT)
Table 120. Middle East & Africa Drugs for Asthma and COPD Revenue by Region (2017-2022) & (USD Million)
Table 121. Middle East & Africa Drugs for Asthma and COPD Revenue by Region (2023-2028) & (USD Million)
Table 122. Middle East & Africa Drugs for Asthma and COPD Sales by Type (2017-2022) & (MT)
Table 123. Middle East & Africa Drugs for Asthma and COPD Sales by Type (2023-2028) & (MT)
Table 124. Middle East & Africa Drugs for Asthma and COPD Sales by Application (2017-2022) & (MT)
Table 125. Middle East & Africa Drugs for Asthma and COPD Sales by Application (2023-2028) & (MT)
Table 126. Drugs for Asthma and COPD Raw Material
Table 127. Key Manufacturers of Drugs for Asthma and COPD Raw Materials
Table 128. Direct Channel Pros & Cons
Table 129. Indirect Channel Pros & Cons
Table 130. Drugs for Asthma and COPD Typical Distributors
Table 131. Drugs for Asthma and COPD Typical Customers
List of Figures
Figure 1. Drugs for Asthma and COPD Picture
Figure 2. Global Drugs for Asthma and COPD Revenue Market Share by Type in 2021
Figure 3. Generic Drugs
Figure 4. Patented Drugs
Figure 5. Global Drugs for Asthma and COPD Revenue Market Share by Application in 2021
Figure 6. Asthma
Figure 7. COPD
Figure 8. Global Drugs for Asthma and COPD Revenue, (USD Million) & (MT): 2017 & 2021 & 2028
Figure 9. Global Drugs for Asthma and COPD Revenue and Forecast (2017-2028) & (USD Million)
Figure 10. Global Drugs for Asthma and COPD Sales (2017-2028) & (MT)
Figure 11. Global Drugs for Asthma and COPD Price (2017-2028) & (USD/Kg)
Figure 12. Global Drugs for Asthma and COPD Production Capacity (2017-2028) & (MT)
Figure 13. Global Drugs for Asthma and COPD Production Capacity by Geographic Region: 2022 VS 2028
Figure 14. Drugs for Asthma and COPD Market Drivers
Figure 15. Drugs for Asthma and COPD Market Restraints
Figure 16. Drugs for Asthma and COPD Market Trends
Figure 17. Global Drugs for Asthma and COPD Sales Market Share by Manufacturer in 2021
Figure 18. Global Drugs for Asthma and COPD Revenue Market Share by Manufacturer in 2021
Figure 19. Drugs for Asthma and COPD Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 20. Top 3 Drugs for Asthma and COPD Manufacturer (Revenue) Market Share in 2021
Figure 21. Top 6 Drugs for Asthma and COPD Manufacturer (Revenue) Market Share in 2021
Figure 22. Global Drugs for Asthma and COPD Sales Market Share by Region (2017-2028)
Figure 23. Global Drugs for Asthma and COPD Revenue Market Share by Region (2017-2028)
Figure 24. North America Drugs for Asthma and COPD Revenue (2017-2028) & (USD Million)
Figure 25. Europe Drugs for Asthma and COPD Revenue (2017-2028) & (USD Million)
Figure 26. Asia-Pacific Drugs for Asthma and COPD Revenue (2017-2028) & (USD Million)
Figure 27. South America Drugs for Asthma and COPD Revenue (2017-2028) & (USD Million)
Figure 28. Middle East & Africa Drugs for Asthma and COPD Revenue (2017-2028) & (USD Million)
Figure 29. Global Drugs for Asthma and COPD Sales Market Share by Type (2017-2028)
Figure 30. Global Drugs for Asthma and COPD Revenue Market Share by Type (2017-2028)
Figure 31. Global Drugs for Asthma and COPD Price by Type (2017-2028) & (USD/Kg)
Figure 32. Global Drugs for Asthma and COPD Sales Market Share by Application (2017-2028)
Figure 33. Global Drugs for Asthma and COPD Revenue Market Share by Application (2017-2028)
Figure 34. Global Drugs for Asthma and COPD Price by Application (2017-2028) & (USD/Kg)
Figure 35. North America Drugs for Asthma and COPD Sales Market Share by Type (2017-2028)
Figure 36. North America Drugs for Asthma and COPD Sales Market Share by Application (2017-2028)
Figure 37. North America Drugs for Asthma and COPD Sales Market Share by Country (2017-2028)
Figure 38. North America Drugs for Asthma and COPD Revenue Market Share by Country (2017-2028)
Figure 39. United States Drugs for Asthma and COPD Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 40. Canada Drugs for Asthma and COPD Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Mexico Drugs for Asthma and COPD Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Europe Drugs for Asthma and COPD Sales Market Share by Type (2017-2028)
Figure 43. Europe Drugs for Asthma and COPD Sales Market Share by Application (2017-2028)
Figure 44. Europe Drugs for Asthma and COPD Sales Market Share by Country (2017-2028)
Figure 45. Europe Drugs for Asthma and COPD Revenue Market Share by Country (2017-2028)
Figure 46. Germany Drugs for Asthma and COPD Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. France Drugs for Asthma and COPD Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. United Kingdom Drugs for Asthma and COPD Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. Russia Drugs for Asthma and COPD Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Italy Drugs for Asthma and COPD Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Asia-Pacific Drugs for Asthma and COPD Sales Market Share by Region (2017-2028)
Figure 52. Asia-Pacific Drugs for Asthma and COPD Sales Market Share by Application (2017-2028)
Figure 53. Asia-Pacific Drugs for Asthma and COPD Sales Market Share by Region (2017-2028)
Figure 54. Asia-Pacific Drugs for Asthma and COPD Revenue Market Share by Region (2017-2028)
Figure 55. China Drugs for Asthma and COPD Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Japan Drugs for Asthma and COPD Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Korea Drugs for Asthma and COPD Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. India Drugs for Asthma and COPD Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Southeast Asia Drugs for Asthma and COPD Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Australia Drugs for Asthma and COPD Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. South America Drugs for Asthma and COPD Sales Market Share by Type (2017-2028)
Figure 62. South America Drugs for Asthma and COPD Sales Market Share by Application (2017-2028)
Figure 63. South America Drugs for Asthma and COPD Sales Market Share by Country (2017-2028)
Figure 64. South America Drugs for Asthma and COPD Revenue Market Share by Country (2017-2028)
Figure 65. Brazil Drugs for Asthma and COPD Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Argentina Drugs for Asthma and COPD Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Middle East & Africa Drugs for Asthma and COPD Sales Market Share by Type (2017-2028)
Figure 68. Middle East & Africa Drugs for Asthma and COPD Sales Market Share by Application (2017-2028)
Figure 69. Middle East & Africa Drugs for Asthma and COPD Sales Market Share by Region (2017-2028)
Figure 70. Middle East & Africa Drugs for Asthma and COPD Revenue Market Share by Region (2017-2028)
Figure 71. Turkey Drugs for Asthma and COPD Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Egypt Drugs for Asthma and COPD Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Saudi Arabia Drugs for Asthma and COPD Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. South Africa Drugs for Asthma and COPD Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Manufacturing Cost Structure Analysis of Drugs for Asthma and COPD in 2021
Figure 76. Manufacturing Process Analysis of Drugs for Asthma and COPD
Figure 77. Drugs for Asthma and COPD Industrial Chain
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
Figure 79. Methodology
Figure 80. Research Process and Data Source
• 日本語訳：喘息及びCOPD治療薬のグローバル市場2022年
• レポートコード：GIR-23F3788 ▷ お問い合わせ（見積依頼・ご注文・質問）